Overview

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab96629 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-FATP2 antibody (ab85801)

  • Purity70 - 90% by HPLC.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • ACSVL1
    • FACVL1
    • FATP 2
    • FATP-2
    • FATP2
    • Fatty acid coenzyme A ligase, very long chain 1
    • Fatty acid transport protein 2
    • Fatty-acid-coenzyme A ligase
    • hFACVL1
    • HsT17226
    • Long chain fatty acid CoA ligase
    • Long-chain-fatty-acid--CoA ligase
    • S27A2_HUMAN
    • Slc27a2
    • Solute carrier family 27 (fatty acid transporter), member 2
    • Solute carrier family 27 member 2
    • THCA CoA ligase
    • THCA-CoA ligase
    • Very long chain acyl CoA synthetase
    • Very long chain fatty acid CoA ligase
    • Very long chain fatty acid coenzyme A ligase 1
    • very long-chain 1
    • Very long-chain acyl-CoA synthetase
    • Very long-chain-fatty-acid-CoA ligase
    • VLACS
    • VLCS
    see all
  • FunctionAcyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precurors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes.
  • Tissue specificityExpressed in liver, kidney, placenta and pancreas.
  • Sequence similaritiesBelongs to the ATP-dependent AMP-binding enzyme family.
  • Cellular localizationEndoplasmic reticulum membrane. Peroxisome membrane. Peripheral membrane associated with the lumenal side of peroxisomes.
  • Information by UniProt

References for Human FATP2 peptide (ab96629)

ab96629 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab96629.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"